Aprepitant regimen is linked to decreased chemotherapy-induced nausea and vomiting in women
1. Aprepitant in conjunction with palonosetron and dexamethasone is associated with increased antiemetic efficacy during FOLFOX or FOLFIRI chemotherapy in...